Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°©»ó»ù Á¾¾ç¿¡¼­ p53, cyclin D1 ¹× c-myc ¹ßÇöÀÇ ÀÇÀÇ Significance of p53, cyclin D1 and c-myc Expressions in Thyroid Tumors

´ëÇѺ´¸®ÇÐȸÁö 2004³â 38±Ç 1È£ p.29 ~ 34
ÀÌÁÖÈ£, ÀüÈ£Á¾, À̹ÌÀÚ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁÖÈ£ ( Li Zhu-Ho ) 
Á¶¼±´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

ÀüÈ£Á¾ ( Jeon Ho-Jong ) 
Á¶¼±´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À̹ÌÀÚ ( Lee Mi-Ja ) 
Á¶¼±´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: The G1/S phase proteins of the cell cycle play critical roles in tumorigenesis and tumor progression. Our aim was to investigate the significance of p53, cyclin D1 and c-myc expressions in thyroid tumors.

Methods: The expressions of these proteins were examined in 217 cases of thyroid tumors and tissues using immunohistochemistry. The results were correlated with lymph node metastasis.

Results: p53 expression was seen in 75.5, 47.5, 66.7, and 50% of papillary carcinomas (PC), follicular carcinomas (FC), undifferentiated carcinomas (UC) and follicular adenomas (FA), respectively. There was a significant difference between these expressions in these tumors and the results in nodular hyperplasia (NH) and normal tissues. Cyclin D1 expression was noted in 80.0, 68.4, 66.7, 61.1 and 79.5% of PC, FC, UC, FA and NH, respectively. c-myc expression was seen in 80.0, 94.2, 66.7, 66.7 and 52.3% of PC, FC, UC, FA and NH, respectively. There was a significant association between the expressions in these tumors and the results in normal tissues. The expressions of p53, cyclin D1 and c-myc were not correlated with lymph node metastasis.

Conclusions: These findings suggest the expressions of p53, cyclin D1 and c-myc may act in the early stage, and participates in tumorigenesis and promoting cell growth.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS